{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=salmeterol+xinafoate&page=2", "query": { "intervention": "salmeterol xinafoate", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 143, "total_pages": 15, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=salmeterol+xinafoate&page=3&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=salmeterol+xinafoate&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-01T21:05:03.034Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00395304", "title": "Childhood Asthma Research and Education (CARE) Network Trial - Best Add-On Therapy Giving Effective Response (BADGER)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "fluticasone propionate + montelukast", "type": "DRUG" }, { "name": "fluticasone propionate", "type": "DRUG" }, { "name": "fluticasone propionate + salmeterol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Milton S. Hershey Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "6 Years to 18 Years" }, "enrollment_count": 182, "start_date": "2007-03", "completion_date": "2011-12", "has_results": true, "last_update_posted_date": "2018-07-02", "last_synced_at": "2026-10-01T21:05:03.034Z", "location_count": 5, "location_summary": "Tucson, Arizona • San Diego, California • Denver, Colorado + 2 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "San Diego", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Madison", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT00395304" }, { "nct_id": "NCT00250341", "title": "Non-invasive Measures of Distal Lung Disease in Asthmatics", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "QVAR", "type": "DRUG" }, { "name": "Advair", "type": "DRUG" }, { "name": "Servent Diskus", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teva Branded Pharmaceutical Products R&D, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 34, "start_date": "2005-09-30", "completion_date": "2007-09-30", "has_results": false, "last_update_posted_date": "2021-12-02", "last_synced_at": "2026-10-01T21:05:03.034Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00250341" }, { "nct_id": "NCT02301975", "title": "An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol 100/25 Microgram (mcg) Inhalation Powder, Fluticasone Propionate/Salmeterol 250/50 mcg Inhalation Powder, and Fluticasone Propionate 250 mcg Inhalation Powder in Adults and Adolescents With Persistent Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Fluticasone Furoate/Vilanterol 100/25 mcg via ELLIPTA inhaler", "type": "DRUG" }, { "name": "Placebo inhalation powders via ELLIPTA inhaler", "type": "DRUG" }, { "name": "Fluticasone Propionate/Salmeterol 250/50 mcg via ACCUHALER/DISKUS inhaler", "type": "DRUG" }, { "name": "Placebo inhalation powder via ACCUHALER/DISKUS inhaler", "type": "DRUG" }, { "name": "Fluticasone Propionate 250 mcg via ACCUHALER/DISKUS inhaler", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 1526, "start_date": "2015-03-01", "completion_date": "2016-11-25", "has_results": true, "last_update_posted_date": "2018-08-06", "last_synced_at": "2026-10-01T21:05:03.034Z", "location_count": 34, "location_summary": "Huntington Beach, California • Riverside, California • Rolling Hills Estates, California + 30 more", "locations": [ { "city": "Huntington Beach", "state": "California" }, { "city": "Riverside", "state": "California" }, { "city": "Rolling Hills Estates", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Upland", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02301975" }, { "nct_id": "NCT01156792", "title": "Safety and Efficacy Study of Adding GSK2190915 to Low Dose Inhaled Corticosteroid Treatment for Asthma Subjects > or = 12 Years of Age", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "FP 100", "type": "DRUG" }, { "name": "GSK2190915 100", "type": "DRUG" }, { "name": "GSK2190915 300", "type": "DRUG" }, { "name": "montelukast", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" }, { "name": "FP/SAL 100/50", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "FEMALE", "summary": "12 Years and older · Female only" }, "enrollment_count": 162, "start_date": "2010-09", "completion_date": "2011-10", "has_results": true, "last_update_posted_date": "2017-04-05", "last_synced_at": "2026-10-01T21:05:03.034Z", "location_count": 32, "location_summary": "Birmingham, Alabama • Little Rock, Arkansas • Huntington Beach, California + 28 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Vista", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01156792" }, { "nct_id": "NCT03219866", "title": "Nebulizer Versus Dry Powdered Inhalers for Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "COPD", "COPD Exacerbation" ], "interventions": [ { "name": "Nebulizers", "type": "DEVICE" }, { "name": "Dry Powder Inhaler", "type": "DEVICE" }, { "name": "Brovana", "type": "DRUG" }, { "name": "Pulmicort", "type": "DRUG" }, { "name": "Atrovent", "type": "DRUG" }, { "name": "Advair Diskus", "type": "DRUG" }, { "name": "Spiriva HandiHaler", "type": "DRUG" } ], "intervention_types": [ "DEVICE", "DRUG" ], "sponsor": "Wake Forest University Health Sciences", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 40, "start_date": "2017-10-03", "completion_date": "2020-04-01", "has_results": true, "last_update_posted_date": "2021-06-22", "last_synced_at": "2026-10-01T21:05:03.034Z", "location_count": 1, "location_summary": "Winston-Salem, North Carolina", "locations": [ { "city": "Winston-Salem", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT03219866" }, { "nct_id": "NCT02680561", "title": "A Double Blind Open Label Comparator Study to Compare Treatments in 4 to 11 Year Old Patients With Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Fluticasone Propionate MDPI", "type": "DRUG" }, { "name": "Fluticasone Propionate/Salmeterol MDPI", "type": "DRUG" }, { "name": "Fluticasone propionate/salmeterol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teva Branded Pharmaceutical Products R&D, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "4 Years to 11 Years" }, "enrollment_count": 20, "start_date": "2016-04", "completion_date": "2016-08", "has_results": false, "last_update_posted_date": "2021-11-09", "last_synced_at": "2026-10-01T21:05:03.034Z", "location_count": 3, "location_summary": "Huntington Beach, California • Raleigh, North Carolina • San Antonio, Texas", "locations": [ { "city": "Huntington Beach", "state": "California" }, { "city": "Raleigh", "state": "North Carolina" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02680561" }, { "nct_id": "NCT00521222", "title": "Evaluating Long Acting Beta Agonists Used to Treat Asthma Among Those With Either Arg/Arg or Gly/Gly Genotypes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Fluticasone with salmeterol", "type": "DRUG" }, { "name": "Fluticasone HFA", "type": "DRUG" }, { "name": "Ipratropium HFA", "type": "DRUG" }, { "name": "Albuterol HFA", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Columbia University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 90, "start_date": "2007-06", "completion_date": "2010-11", "has_results": true, "last_update_posted_date": "2023-04-21", "last_synced_at": "2026-10-01T21:05:03.034Z", "location_count": 3, "location_summary": "Hackensack, New Jersey • New York, New York", "locations": [ { "city": "Hackensack", "state": "New Jersey" }, { "city": "New York", "state": "New York" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00521222" }, { "nct_id": "NCT01817764", "title": "A Study to Compare the Efficacy and Safety of Umeclidinium/Vilanterol and Fluticasone Propionate/Salmeterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Umeclidinium/vilanterol", "type": "DRUG" }, { "name": "Fluticasone propionate/salmeterol", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 707, "start_date": "2013-03-01", "completion_date": "2013-10-25", "has_results": true, "last_update_posted_date": "2017-11-08", "last_synced_at": "2026-10-01T21:05:03.034Z", "location_count": 9, "location_summary": "Jasper, Alabama • Phoenix, Arizona • San Diego, California + 6 more", "locations": [ { "city": "Jasper", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "San Diego", "state": "California" }, { "city": "Clearwater", "state": "Florida" }, { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT01817764" }, { "nct_id": "NCT00274534", "title": "A Comparison of the Effects of Tiotropium Inhalation qd and Salmeterol Inhalation Bid on Arterial Blood Gases.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Tiotropium", "type": "DRUG" }, { "name": "Salmeterol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 36, "start_date": "2000-12", "completion_date": "2003-07", "has_results": false, "last_update_posted_date": "2013-11-05", "last_synced_at": "2026-10-01T21:05:03.034Z", "location_count": 2, "location_summary": "Hines, Illinois • Richmond, Virginia", "locations": [ { "city": "Hines", "state": "Illinois" }, { "city": "Richmond", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00274534" }, { "nct_id": "NCT02024204", "title": "Uncontrolled Lower Respiratory Symptoms in the WTC Survivor Program", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Lung Diseases", "Medication Compliance" ], "interventions": [ { "name": "Fluticasone propionate 230mcg for 3 Months", "type": "DRUG" }, { "name": "Current Treatment or no treatment", "type": "DRUG" }, { "name": "Salmeterol 21mcg for 3 Months", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "NYU Langone Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 60, "start_date": "2014-04-09", "completion_date": "2017-05-17", "has_results": true, "last_update_posted_date": "2021-02-02", "last_synced_at": "2026-10-01T21:05:03.034Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02024204" } ] }